These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15553363)

  • 1. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    van den Bliek BM; Maas HA
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2149; author reply 2149. PubMed ID: 15553363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    Kalisvaart CJ; Boelaarts L; de Jonghe JF; Hovinga IM; Kat MG
    Ned Tijdschr Geneeskd; 2004 Jul; 148(30):1501-4. PubMed ID: 15481575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delirium in elderly hospitalised patients: protective effects of chronic rivastigmine usage.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Int J Geriatr Psychiatry; 2004 Jul; 19(7):641-4. PubMed ID: 15254920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rivastigmine treatment of Othello syndrome and post-ECT delirium in a patient with Parkinson's disease.
    Scicutella A
    J Neuropsychiatry Clin Neurosci; 2015; 27(1):e90. PubMed ID: 25716514
    [No Abstract]   [Full Text] [Related]  

  • 5. Alzheimer's drug proves ineffective for delirium.
    Harv Ment Health Lett; 2011 Mar; 27(9):7. PubMed ID: 21476248
    [No Abstract]   [Full Text] [Related]  

  • 6. Cholinesterase inhibitor treatment in patients with delirium.
    Frölich L; Förstl H
    Lancet; 2011 Mar; 377(9769):899; author reply 901. PubMed ID: 21397755
    [No Abstract]   [Full Text] [Related]  

  • 7. Cholinesterase inhibitor treatment in patients with delirium.
    Berg RM; Möller K
    Lancet; 2011 Mar; 377(9769):900; author reply 901. PubMed ID: 21397758
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholinesterase inhibitor treatment in patients with delirium.
    de Pont AC; van Geer MA; Schultz MJ
    Lancet; 2011 Mar; 377(9769):899; author reply 901. PubMed ID: 21397757
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor.
    Fischer P
    J Clin Psychopharmacol; 2001 Feb; 21(1):118. PubMed ID: 11199939
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinesterase inhibition as a possible therapy for delirium in vascular dementia: a controlled, open 24-month study of 246 patients.
    Moretti R; Torre P; Antonello RM; Cattaruzza T; Cazzato G
    Am J Alzheimers Dis Other Demen; 2004; 19(6):333-9. PubMed ID: 15633941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of delirium following cardiac surgery.
    Groen JA; Banayan D; Gupta S; Xu S; Bhalerao S
    J Card Surg; 2012 Sep; 27(5):589-93. PubMed ID: 22978835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unsubstantiated superiority claims for rivastigmine tartrate.
    Shah SK; Krueger PM
    J Am Osteopath Assoc; 2006 Oct; 106(10):589-90; author reply 590. PubMed ID: 17122027
    [No Abstract]   [Full Text] [Related]  

  • 14. A pilot study of rivastigmine in the treatment of delirium after stroke: a safe alternative.
    Oldenbeuving AW; de Kort PL; Jansen BP; Kappelle LJ; Roks G
    BMC Neurol; 2008 Sep; 8():34. PubMed ID: 18803862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].
    Schölzel-Dorenbos CJ;
    Tijdschr Gerontol Geriatr; 2005 Jul; 36(3):122-6. PubMed ID: 16078659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of switching from an AChE inhibitor to a dual AChE-BuChE inhibitor in patients with Alzheimer's disease.
    Bartorelli L; Giraldi C; Saccardo M; Cammarata S; Bottini G; Fasanaro AM; Trequattrini A;
    Curr Med Res Opin; 2005 Nov; 21(11):1809-18. PubMed ID: 16307702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment.
    Dantoine T; Auriacombe S; Sarazin M; Becker H; Pere JJ; Bourdeix I
    Int J Clin Pract; 2006 Jan; 60(1):110-8. PubMed ID: 16409439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding rivastigmine to antipsychotics in the treatment of a chronic delirium.
    Dautzenberg PL; Mulder LJ; Olde Rikkert MG; Wouters CJ; Loonen AJ
    Age Ageing; 2004 Sep; 33(5):516-7. PubMed ID: 15315924
    [No Abstract]   [Full Text] [Related]  

  • 19. Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome.
    Prasher VP; Fung N; Adams C
    Int J Geriatr Psychiatry; 2005 May; 20(5):496-7. PubMed ID: 15852458
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
    Noble JM; Hauser WA
    Neurology; 2007 May; 68(20):1749; author reply 1750. PubMed ID: 17502565
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.